Axonics Investor Relations Material
Latest events
Q3 2023
Axonics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Axonics Inc
Access all reports
Axonics, Inc. is a medical technology company specializing in implantable devices for the treatment of bladder and bowel dysfunction. The company develops and markets sacral neuromodulation systems designed to provide long-term relief for patients with conditions such as overactive bladder, urinary retention, and fecal incontinence. Axonics focuses on innovative, patient-friendly solutions that enhance the quality of life and offer alternatives to traditional treatments. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
AXNX
Country
🇺🇸 United States